Sell-Side M&A · Dental & Aesthetic Practices
Know What Your Practice
Is Actually Worth.
Whether you’re a GP ready to retire, an orthodontist considering a DSO partnership, or a medspa owner watching PE roll through your market — the decisions you make in the next 12 months will define your financial outcome for decades.
Dental · Orthodontics · Periodontics · Endodontics · Oral Surgery · Medspa · Dermatology · Plastic Surgery · Aesthetic Spa · Functional Health
Why 2025–2027 Is a Defining Window
Private equity has been consolidating dental and aesthetic practices for over a decade. What’s changed is the pace — and the pressure. DSO platforms are competing for the same practices. Medspa rollups are accelerating. And multiples, while still strong, are not immune to interest rate and lending environment shifts.
DSO competition is elevating GP multiples. Specialty practices with strong referral networks command the top of range.
The most active PE rollup category in healthcare. Plastic surgery and derm with real EBITDA are attracting serious strategic buyers.
Lending conditions, buyer appetite, and demographic timing all converge in the next 24–36 months. Waiting costs options, not just time.
Dental & Aesthetic — Full Coverage
3x – 6x EBITDA
The foundation of DSO consolidation. Solo practices with hygiene revenue, low patient concentration, and digital workflows command the top of range. DSO competition has compressed days-on-market.
4x – 8x EBITDA
The most active specialty for PE. Multi-location practices with strong case starts and clean patient records have seen competitive offer situations. Aligner-heavy practices with subscription-style revenue attract top multiples.
3.5x – 7x EBITDA
Strong referral networks and implant placement revenue drive multiples above GPs. Increasing GP-to-specialist referral traffic makes perio practices recurring-revenue assets to buyers.
4x – 7.5x EBITDA
Referral-dependent practices with cone beam CT and rotary instrumentation. High per-procedure revenue and minimal overhead expansion make endo practices highly attractive to DSO specialty networks.
5x – 9x EBITDA
The highest-multiple dental specialty. Implant-heavy practices with in-house anesthesia, hospital privileges, and multi-surgeon capacity attract both strategic buyers and PE platforms building surgical networks.
4x – 8x EBITDA
The most active rollup category in aesthetics. Multi-location operators with membership programs, retail revenue, and physician oversight are seeing competitive acquisition timelines. State-specific MSO/PC structures matter.
5x – 10x EBITDA
Medical derm commands premium multiples driven by Mohs surgery, pathology revenue, and cosmetic add-on services. PE interest has been sustained for 5+ years with no sign of slowing.
6x – 12x EBITDA
The highest EBITDA multiples in aesthetics. Body and facial practices with real surgical volume and accredited ASCs attract the most sophisticated buyers. Revenue quality matters more than size.
3x – 6x EBITDA
Non-medical or hybrid aesthetic spas with strong retail, membership, and high-revenue service menus. Proper scope of practice and physician oversight documentation is critical to buyer due diligence.
3x – 6x EBITDA
Hormone therapy, weight management, IV therapy, and longevity medicine. The fastest-growing adjacent vertical. Subscription-based membership models and cash-pay revenue structures are highly attractive to PE.
Know Your Numbers Before Anyone Else Does
Data-driven, instant estimates benchmarked against real closed transactions. No obligation, no sales call required to use them.
Dental Practice Valuation
GP, Ortho, Perio, Endo, and Oral Surgery — enter your practice profile and get an instant valuation range with PE vs. strategic buyer comparison.
Aesthetic Practice Valuation
Medspa, dermatology, plastic surgery, aesthetic spa, and functional health — instant estimate covering strategic and PE buyer scenarios.
EBITDA & P&L Recast Calculator
Enter your P&L line by line and build an adjusted EBITDA figure a buyer will actually underwrite. The fastest way to see what your financials look like from the other side of the table.
Results are estimates based on industry benchmarks and are not a substitute for a formal appraisal. For a full CPA-backed analysis, request a free prospectus.
Every Practice Owner Has More Options Than They Think
The most common mistake practice owners make is going into a transaction without understanding all the paths available. Here’s an honest breakdown.
Not sure which path fits your situation? That’s exactly what the free prospectus is designed to clarify. Start here →
Built Around Information, Not Pressure
Most practice owners enter sale conversations without a full picture of what they have. I fix that first.
Full Practice Diagnosis
We review financials, payer mix, staffing structure, lease, patient concentration, and clinical profile — building the picture a buyer will build before we do it first.
Specialist Review
In-house CPA, real estate, and market comp teams review every element independently — so nothing affecting your value is missed or underestimated.
All Options, Clearly Laid Out
DSO vs. strategic buyer vs. individual buyer — every scenario modeled, every valuation range documented. No pressure toward any particular direction.
Your Decision, Your Timeline
Go to market now, optimize first, or simply keep the information on file. That’s entirely your call — no obligation, no follow-up pressure.
Maximum Leverage at the Table
When you’re ready, we run a structured process — competitive buyer environment, real offers, real negotiating leverage across all buyer types simultaneously.
The Platform Behind the Advisor
Day Listing Agreement
We offer 30-day agreements vs. the industry-standard 1-year contract. You sell when the time is right for you, not us.
Upfront Fees
No retainers, no upfront costs, no cancellation penalties. One broker fee, collected only after a transaction successfully closes.
In-House Specialty Teams
CPA, real estate, equipment, and market comp — all in-house. No outsourced guesswork, no referral fees, no delays.
We Give Back in Your Name
PTS is a social impact company. A portion of every broker fee goes to a nonprofit of your choice — in your name — after your transaction closes.
Get Your Free Practice Valuation Prospectus
A CPA-backed valuation benchmarked against real closed transactions — completely free. Whether you’re ready to move or simply want to understand where you stand.
Full market valuation from real closed comps · PE platform vs. strategic buyer comparison · CPA-underwritten · Improvement opportunities documented
Completely free, always · No cancellation penalties · All conversations are confidential · You decide if and when to act
You fill out the form. I reach out personally within one business day. We schedule a 20-minute call with zero obligation to proceed.
“You can never start too early or have too much information. The sooner you understand your position, the more options you have.”